Eagle Point Income Company Inc. Announces Second Quarter 2024 Common and Preferred Distributions
GREENWICH, Conn.–(BUSINESS WIRE)–$EIC–Eagle Point Income Company Inc. (the “Company”) (NYSE: EIC, EICA, EICB) today is pleased to announce... Read more.
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Xponential Fitness, Inc. (XPOF) Investors
NEW YORK–(BUSINESS WIRE)–$XPOF #ClassActionLawsuit–The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in... Read more.
Shoe Carnival Acquires Rogan’s Shoes and Announces Full Year Fiscal 2023 Preliminary Results
Acquisition Expected to Generate Over $10 Million in Operating Income Post Integration Completion Provides Market Leadership in Wisconsin and Expands Retail Store... Read more.
Danaos Corporation Reports Results for the Fourth Quarter and Year Ended December 31, 2023
ATHENS, Greece–(BUSINESS WIRE)–Danaos Corporation (“Danaos”) (NYSE: DAC), one of the world’s largest independent owners of containerships, today... Read more.
Similarweb Announces Fourth Quarter and Fiscal Year 2023 Results
Delivers positive free cash for the first time since IPO Non-GAAP operating profit margin of 8% TEL AVIV, Israel–(BUSINESS WIRE)–Similarweb Ltd. (NYSE:... Read more.
ElectraMeccanica Announces Filing and Mailing of the Joint Proxy Statement/Management Information Circular in Connection with its Special Meeting of Shareholders to Approve the Proposed Combination with Xos
Your vote is important no matter how many votes you hold. The Board of Directors of ElectraMeccanica recommends that Shareholders vote IN FAVOR of the ElectraMeccanica... Read more.
Bright Horizons Family Solutions Reports Fourth Quarter and Full Year 2023 Financial Results
NEWTON, Mass.–(BUSINESS WIRE)–Bright Horizons Family Solutions® Inc. (NYSE: BFAM) today announced financial results for the fourth quarter and full... Read more.
Vistagen Reports Fiscal 2024 Third Quarter Financial Results and Provides Corporate Update
Fasedienol PALISADE Phase 3 program for the acute treatment of social anxiety disorder remains on track PALISADE-3 trial initiation anticipated in 1H 2024; PALISADE-4... Read more.
Merrimack Reports Ipsen Announcement of Approval By The US FDA of Onivyde® (Irinotecan Liposome Injection) Plus 5 Fluorouracil/Leucovorin and Oxaliplatin (NALIRIFOX) as a First-Line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)
FDA Approval Triggers $225 Million Milestone Payment from Ipsen to Merrimack Merrimack Expects to Hold Special Meeting of Stockholders to Approve Plan of Dissolution... Read more.
Matador Resources Company Declares Quarterly Cash Dividend
DALLAS–(BUSINESS WIRE)–Matador Resources Company (NYSE: MTDR) (“Matador”) today announced that its Board of Directors declared a quarterly cash dividend... Read more.